# The Chinese University of Hong Kong Early Arthritis Study

> **NCT00901550** · NA · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 40 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT00901550
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00901550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00901550, "The Chinese University of Hong Kong Early Arthritis Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00901550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*